Mesa Laboratories (MLAB) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

Mesa Laboratories Revenue Highlights

Latest Revenue (Y)

$249.13M

Latest Revenue (Q)

$65.13M

Main Segment (Y)

Sterilization and Disinfection Control

Main Geography (Y)

UNITED STATES

Mesa Laboratories Revenue by Period

Mesa Laboratories Revenue by Year

Date	Revenue	Change
2026-03-31	$249.13M	3.38%
2025-03-31	$240.98M	11.47%
2024-03-31	$216.19M	-1.32%
2023-03-31	$219.08M	18.85%
2022-03-31	$184.34M	37.63%
2021-03-31	$133.94M	13.81%
2020-03-31	$117.69M	14.11%
2019-03-31	$103.14M	7.23%
2018-03-31	$96.18M	2.68%
2017-03-31	$93.67M	10.64%
2016-03-31	$84.66M	18.69%
2015-03-31	$71.33M	35.29%
2014-03-31	$52.72M	13.54%
2013-03-31	$46.44M	17.21%
2012-03-31	$39.62M	20.68%
2011-03-31	$32.83M	49.69%
2010-03-31	$21.93M	1.82%
2009-03-31	$21.54M	10.11%
2008-03-31	$19.56M	13.43%
2007-03-31	$17.24M	48.86%
2006-03-31	$11.58M	15.36%
2005-03-31	$10.04M	10.03%
2004-03-31	$9.13M	0.49%
2003-03-31	$9.08M	0.42%
2002-03-31	$9.04M	-0.62%
2001-03-31	$9.10M	5.14%
2000-03-31	$8.66M	6.86%
1999-03-31	$8.10M	2.53%
1998-03-31	$7.90M	1.28%
1997-03-31	$7.80M	-3.70%
1996-03-31	$8.10M	22.73%
1995-03-31	$6.60M	6.45%
1994-03-31	$6.20M	-

Mesa Laboratories generated $249.13M in revenue during NA 2026, up 3.38% compared to the previous quarter, and up 186.01% compared to the same period a year ago.

Mesa Laboratories Revenue by Quarter

Date	Revenue	Change
2025-12-31	$65.13M	7.23%
2025-09-30	$60.74M	2.01%
2025-06-30	$59.54M	-4.17%
2025-03-31	$62.13M	-1.12%
2024-12-31	$62.84M	8.66%
2024-09-30	$57.83M	-0.58%
2024-06-30	$58.17M	-1.25%
2024-03-31	$58.90M	10.16%
2023-12-31	$53.47M	0.58%
2023-09-30	$53.16M	4.98%
2023-06-30	$50.65M	-8.90%
2023-03-31	$55.59M	2.40%
2022-12-31	$54.29M	-7.60%
2022-09-30	$58.75M	16.44%
2022-06-30	$50.45M	-14.31%
2022-03-31	$58.88M	7.65%
2021-12-31	$54.70M	52.61%
2021-09-30	$35.84M	2.63%
2021-06-30	$34.92M	-8.02%
2021-03-31	$37.96M	11.10%
2020-12-31	$34.17M	7.26%
2020-09-30	$31.86M	6.41%
2020-06-30	$29.94M	-12.47%
2020-03-31	$34.21M	8.07%
2019-12-31	$31.66M	23.96%
2019-09-30	$25.54M	-2.86%
2019-06-30	$26.29M	-0.60%
2019-03-31	$26.45M	-0.88%
2018-12-31	$26.68M	7.31%
2018-09-30	$24.86M	-1.10%
2018-06-30	$25.14M	-6.47%
2018-03-31	$26.88M	13.56%
2017-12-31	$23.67M	3.12%
2017-09-30	$22.95M	1.24%
2017-06-30	$22.67M	-6.69%
2017-03-31	$24.30M	1.91%
2016-12-31	$23.84M	-2.32%
2016-09-30	$24.41M	15.61%
2016-06-30	$21.11M	-14.90%
2016-03-31	$24.81M	24.60%
2015-12-31	$19.91M	-8.56%
2015-09-30	$21.78M	19.93%
2015-06-30	$18.16M	-2.17%
2015-03-31	$18.56M	4.09%
2014-12-31	$17.83M	-3.83%
2014-09-30	$18.54M	13.05%
2014-06-30	$16.40M	4.37%
2014-03-31	$15.71M	19.81%
2013-12-31	$13.12M	3.47%
2013-09-30	$12.68M	13.00%
2013-06-30	$11.22M	-12.41%
2013-03-31	$12.81M	12.74%
2012-12-31	$11.36M	-2.95%
2012-09-30	$11.71M	10.86%
2012-06-30	$10.56M	-13.29%
2012-03-31	$12.18M	31.53%
2011-12-31	$9.26M	-0.34%
2011-09-30	$9.29M	4.53%
2011-06-30	$8.89M	-10.81%
2011-03-31	$9.96M	30.23%
2010-12-31	$7.65M	-1.32%
2010-09-30	$7.75M	4.01%
2010-06-30	$7.46M	19.72%
2010-03-31	$6.23M	17.09%
2009-12-31	$5.32M	-1.65%
2009-09-30	$5.41M	8.64%
2009-06-30	$4.98M	-8.93%
2009-03-31	$5.46M	2.40%
2008-12-31	$5.34M	-6.02%
2008-09-30	$5.68M	12.37%
2008-06-30	$5.05M	-12.71%
2008-03-31	$5.79M	-

Mesa Laboratories generated $65.13M in revenue during Q3 2026, up 7.23% compared to the previous quarter, and up 112.61% compared to the same period a year ago.

Mesa Laboratories Revenue Breakdown

Mesa Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Biopharmaceutical Development	$48.63M	$40.71M	-	-	-
Clinical Genomics	$45.39M	$52.59M	-	-	-
Calibration Solutions	$53.55M	$47.76M	-	-	-
Sterilization and Disinfection Control	$101.57M	$75.12M	-	-	-
Product	-	$198.40M	$180.52M	$149.42M	-
Service	-	$42.58M	$38.56M	-	-

Mesa Laboratories's latest annual revenue breakdown by segment (product or service), as of Mar 26: Sterilization and Disinfection Control (40.77%), Calibration Solutions (21.50%), Biopharmaceutical Development (19.52%), and Clinical Genomics (18.22%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
Sterilization and Disinfection Control	$29.14M	$24.91M	$22.11M	$25.41M	$22.78M	$19.34M	$17.08M	$15.93M	$15.42M	$13.08M	-	-	-	-	-	-	-	-	-	-
Clinical Genomics	$12.18M	$11.77M	$11.14M	$10.30M	$11.12M	$12.55M	$15.55M	$13.37M	-	-	-	-	-	-	-	-	-	-	-	-
Calibration Solutions	$13.56M	$14.07M	$13.57M	$12.35M	$12.81M	$12.16M	$11.33M	$11.46M	-	-	-	-	-	-	-	-	-	-	-	-
Biopharmaceutical Development	$8.85M	$14.37M	$13.92M	$11.49M	$12.19M	$9.43M	$9.21M	$9.89M	$10.10M	$8.71M	-	-	-	-	-	-	-	-	-	-
Product	-	-	-	-	$19.55M	$62.84M	$57.83M	$54.29M	$58.75M	$50.45M	$23.97M	$54.70M	$35.84M	$34.92M	-	-	-	-	-	-
Continuous Monitoring	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$4.18M	$3.41M
Instruments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$8.26M	$8.97M

Mesa Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Sterilization and Disinfection Control (45.72%), Calibration Solutions (21.28%), Clinical Genomics (19.12%), and Biopharmaceutical Development (13.88%).

Mesa Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
CHINA	$20.45M	$25.31M	$24.93M	$25.80M	-
UNITED STATES	$116.89M	$116.61M	$106.39M	$117.28M	$99.07M
Other	$111.79M	$99.05M	$84.86M	$76.00M	-
Product	-	-	-	-	$149.42M
Non-US	-	-	-	-	$85.27M

Mesa Laboratories's latest annual revenue breakdown by geography, as of Mar 26: UNITED STATES (46.92%), Other (44.87%), and CHINA (8.21%).

Quarterly Revenue by Country

Country	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
CHINA	$4.06M	$5.64M	$5.32M	$5.43M	$5.04M	$6.32M	$7.39M	$6.35M	$4.94M	$7.53M	$6.11M	$7.48M	$7.48M	-	-	-	-	-	-	-
UNITED STATES	$30.06M	$29.89M	$29.30M	$27.65M	$31.20M	$30.48M	$28.08M	$27.19M	$25.59M	$27.07M	$26.54M	$28.64M	$30.99M	$29.12M	$30.82M	$30.41M	$19.38M	$18.45M	$19.14M	$18.48M
Other	$29.61M	$29.59M	$26.12M	$26.47M	$25.89M	$26.04M	$22.36M	$25.36M	$22.94M	$18.56M	$18.00M	$18.16M	$20.28M	-	-	-	-	-	-	-
Non-US	-	-	-	-	-	-	-	-	-	-	-	-	-	$21.33M	$28.06M	$24.28M	$16.46M	$16.46M	$18.82M	$15.69M

Mesa Laboratories's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (47.17%), Other (46.46%), and CHINA (6.37%).

Mesa Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
GRVY	Gravity	$713.44B	$119.78B
LPTH	LightPath	$37.20B	$19.15T
XRX	Xerox	$7.02B	$1.85B
GDEV	GDEV	$465.00M	$107.00M
VPG	Vishay Precision Group	$307.20M	$84.35M
PUBM	PubMatic	$282.93M	$62.57M
MLAB	Mesa Laboratories	$249.13M	$65.13M
EGAN	eGain	$88.43M	$22.50M
GRRR	Gorilla Technology Group	$64.69M	$26.73M
BZAI	Blaize	$1.55M	$1.00K
MVIS	MicroVision	$1.21M	$935.00K

MLAB Revenue FAQ

What is Mesa Laboratories’s yearly revenue?

Mesa Laboratories's yearly revenue for 2026 was $249.13M, representing an increase of 3.38% compared to 2025. The company's yearly revenue for 2025 was $240.98M, representing an increase of 11.47% compared to 2024. MLAB's yearly revenue for 2024 was $216.19M, representing a decrease of -1.32% compared to 2023.

What is Mesa Laboratories’s quarterly revenue?

Mesa Laboratories's quarterly revenue for Q3 2026 was $65.13M, a 7.23% increase from the previous quarter (Q2 2026), and a 3.64% increase year-over-year (Q3 2025). The company's quarterly revenue for Q2 2026 was $60.74M, a 2.01% increase from the previous quarter (Q1 2026), and a 5.02% increase year-over-year (Q2 2025). MLAB's quarterly revenue for Q1 2026 was $59.54M, a -4.17% decrease from the previous quarter (Q4 2025), and a 2.36% increase year-over-year (Q1 2025).

What is Mesa Laboratories’s revenue growth rate?

Mesa Laboratories's revenue growth rate for the last 3 years (2024-2026) was 15.24%, and for the last 5 years (2022-2026) was 35.15%.

What are Mesa Laboratories’s revenue streams?

Mesa Laboratories's revenue streams in r 26 are Biopharmaceutical Development, Clinical Genomics, Calibration Solutions, and Sterilization and Disinfection Control. Biopharmaceutical Development generated $48.63M in revenue, accounting 19.52% of the company's total revenue, up 19.44% year-over-year. Clinical Genomics generated $45.39M in revenue, accounting 18.22% of the company's total revenue, down -13.70% year-over-year. Calibration Solutions generated $53.55M in revenue, accounting 21.50% of the company's total revenue, up 12.12% year-over-year. Sterilization and Disinfection Control generated $101.57M in revenue, accounting 40.77% of the company's total revenue, up 35.20% year-over-year.

What is Mesa Laboratories’s main source of revenue?

For the fiscal year ending Mar 26, the largest source of revenue of Mesa Laboratories was Sterilization and Disinfection Control. This segment made a revenue of $101.57M, representing 40.77% of the company's total revenue.